[Role of endogenous cannabinoids in cerebral reward mechanisms]
- PMID: 15125311
[Role of endogenous cannabinoids in cerebral reward mechanisms]
Abstract
Central cannabinoid receptors (CB1 receptors) are densely located in the output nuclei of the basal ganglia (globus pallidus, substantia nigra pars reticulata). Endogenous cannabinoids appear to modulate transmitter systems (e.g. dopamine) within the basal ganglia. In the striatum, CB1 receptors are localized on the same neurons as Gi-coupled dopamine D2 receptors. Striatal CB1 receptors are also negatively linked to adenylcyase, and may modulate dopamine release. The presence of CB1 receptors in dopaminergic neurons strongly suggests that cannabinoids play a modulatory role in dopaminergic neuronal pathways. This co-localization may postulate "cross talk" between endocannabinoids and dopamine-dependent reward mechanisms.
Similar articles
-
The pharmacology of cannabinoid receptors and their ligands: an overview.Int J Obes (Lond). 2006 Apr;30 Suppl 1:S13-8. doi: 10.1038/sj.ijo.0803272. Int J Obes (Lond). 2006. PMID: 16570099 Review.
-
The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.Arch Mal Coeur Vaiss. 2006 Mar;99(3):242-6. Arch Mal Coeur Vaiss. 2006. PMID: 16618028 Review.
-
Cannabinoid signalling in the enteric nervous system.Neurogastroenterol Motil. 2009 Sep;21(9):899-902. doi: 10.1111/j.1365-2982.2009.01372.x. Neurogastroenterol Motil. 2009. PMID: 19689654
-
Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.J Chem Neuroanat. 2009 Jul;37(4):266-81. doi: 10.1016/j.jchemneu.2009.02.001. Epub 2009 Feb 21. J Chem Neuroanat. 2009. PMID: 19481011
-
Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.Exp Neurol. 2004 Oct;189(2):393-403. doi: 10.1016/j.expneurol.2004.05.041. Exp Neurol. 2004. PMID: 15380489
Cited by
-
Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.Neuropharmacology. 2012 Jun;62(7):2192-201. doi: 10.1016/j.neuropharm.2012.01.013. Epub 2012 Jan 25. Neuropharmacology. 2012. PMID: 22306525 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous